Plus Therapeutics News

Plus Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow JonesDec 9 04:50 ET

Plus Therapeutics Analyst Ratings

BenzingaDec 9 04:40 ET

H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 26 06:31 ET

Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 16 11:33 ET

Positive Outlook for Plus Therapeutics: Strong Financial Support and Clinical Advancements Justify Buy Rating

TipRanksNov 16 10:47 ET

Plus Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow JonesNov 15 07:31 ET

Plus Therapeutics Analyst Ratings

BenzingaNov 15 07:20 ET

H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 15 06:31 ET

Buy Rating Affirmed for Plus Therapeutics Amidst ReSPECT-GBM Trial Progress and Overlooked Market Potential

TipRanksOct 2 08:35 ET

Plus Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow JonesSep 3 05:45 ET

Buy Rating Affirmed for Plus Therapeutics Amid Strong Clinical Results and Positive Financial Outlook

TipRanksAug 20 04:57 ET

Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 16 13:32 ET

Buy Rating Affirmed for Plus Therapeutics on Strong Financials and Promising Clinical Trials

TipRanksAug 16 12:47 ET

Plus Therapeutics Analyst Ratings

BenzingaAug 16 08:20 ET

Buy Rating Affirmed for Plus Therapeutics Amidst Promising Clinical Trial Results

TipRanksAug 15 14:37 ET

Buy Rating Affirmed for Plus Therapeutics on Strong Clinical Progress and Robust Financial Health

TipRanksJun 3 06:05 ET

Buy Rating Justified by Plus Therapeutics' Strategic Acquisition and Strong Pipeline Prospects

TipRanksMay 23 07:40 ET

Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)

TipRanksMay 17 16:15 ET

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)

TipRanksMay 10 08:45 ET

Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds

TipRanksMar 22 12:50 ET